Sign in

You're signed outSign in or to get full access.

Emily White

Director at OLAPLEX HOLDINGS
Board

About Emily White

Emily White, age 46, has served on Olaplex’s Board since August 2021 and is a Class II director with a term expiring in 2026. She is President of Anthos Capital (since 2018) and previously held senior operating roles at Snapchat (COO), Facebook/Instagram (led monetization), and Google (ran NA Online Sales & Ops; APAC & LATAM businesses; Emerging Business channel). She holds a B.A. in Art History from Vanderbilt University. Her board skills include retail industry expertise, international markets, strategy, marketing/brand development, and senior leadership, as reflected in Olaplex’s director skills matrix .

Past Roles

OrganizationRoleTenureCommittees/Impact
Anthos CapitalPresident2018–presentInvests in technology/growth; executive leadership
SnapchatChief Operating Officer2014–2015Scaled operations; platform monetization context
Facebook/InstagramMultiple leadership roles; led Instagram business-side monetization2010–2013Built/launched monetization products; revenue focus
GoogleRan NA Online Sales & Ops; APAC & LATAM; Emerging Business channel2001–2010Global expansion; operating scale

External Roles

OrganizationRoleTenureCommittees/Impact
lululemon athletica inc.Director (current)Not disclosedNot disclosed
Gretel Labs, Inc.Director (current)Not disclosedNot disclosed
Guayakí Yerba Mate, S.P.C.Director (current)Not disclosedNot disclosed
Northern Star Investment Corp. IVDirector (prior)2021–2023Not disclosed
Graco Inc.Director (prior)2018–2022Not disclosed
Zayo Group Holdings, Inc.Director (prior)2017–2020Not disclosed
NCWIT (non-profit)Board member (prior)Not disclosedDiversity in computing
X-Prize (non-profit)Board member (prior)Not disclosedInnovation-focused governance

Board Governance

  • Committee assignments: Member, Nominating and Corporate Governance Committee; Chair is Deirdre Findlay .
  • Committee meetings FY2024: Audit (5), Compensation (4), Nominating & Corporate Governance (4) .
  • Attendance: The Board met four times in FY2024; no director attended fewer than 75% of aggregate Board and committee meetings; 82% of directors attended the 2024 annual meeting .
  • Lead Director: Tricia Glynn (separate from Executive Chair) .
  • Controlled company: Advent Funds hold ~75% voting power; Olaplex relies on Nasdaq controlled-company exemptions (Compensation and Nominating committees may include non-independent directors; Audit remains fully independent) .

Fixed Compensation

MetricFY2024Notes
Fees earned or paid in cash ($)$110,000 Implies $100,000 base director retainer + $10,000 Nominating & Corporate Governance committee membership fee
Stock awards ($)$150,000 (RSUs grant date fair value) Annual director RSU grant policy targets ~$150,000 for non-chair directors; vests one year from grant
Total ($)$260,000 Sum of cash retainer and RSUs
RSUs outstanding (#)76,142 (eligible to vest July 16, 2025) One-year vest from grant cycle
Stock options outstanding (#)Not listed for Emily White Options table does not include Emily White

Policy reference:

  • Cash retainers: $100,000 director; committee membership—Audit $15,000 ($30,000 chair), Compensation $10,000 ($20,000 chair), Nominating $10,000 ($15,000 chair); Lead Director $120,000; Chair $150,000 .
  • Annual RSU grant: ~$150,000 (non-chair); vests on first anniversary of grant .

Performance Compensation

  • Directors: No performance-based equity disclosed; RSUs vest time-based. No director options or PSUs tied to metrics for Emily White were disclosed .
  • Company-wide FY2024 executive bonus metrics (context for governance quality):
    • Weighting: 2/3 net sales; 1/3 adjusted EBITDA .
    • Results: Net sales $423M; adjusted EBITDA $130M; payout determined at 46% of target plus 14% discretionary for 60% aggregate payout to maintain retention and accountability .
Net Sales (FY2024, $M)% of Net Sales Portion Earned
41225%
42450%
43775%
449–467100%
479125%
481130%
Actual: 423Within payout schedule noted; combined payout 46% pre-discretion
Adjusted EBITDA (FY2024, $M)% of EBITDA Portion Earned
12725%
13550%
14275%
150–160100%
166125%
167130%
Actual: 130Within payout schedule noted; combined payout 46% pre-discretion

Other Directorships & Interlocks

  • Interlocks: Multiple Olaplex directors also serve at lululemon (Emily White current; David Mussafer current; Martha Morfitt is chair), indicating dense board networks that may enhance information flow but require independence safeguards .
  • Advent influence: Advent Funds control ~75% voting; Emily is not an Advent employee; she is President of Anthos Capital with significant beneficial ownership via Anthos vehicles (see Equity Ownership) .

Expertise & Qualifications

  • Technology and platform monetization (Snapchat, Facebook/Instagram, Google) .
  • Retail/consumer brand insights; marketing and strategy expertise .
  • Service on other public company boards; international markets; senior leadership (skills matrix) .

Equity Ownership

HolderShares Beneficially Owned% of OutstandingNotes
Emily White23,686,4383.6%Held via Anthos Capital IV (23,476,117), Anthos Tribe (148,064), Anthos Management (62,257); spouse Bryan Kelly is manager of Anthos GPs; Emily disclaims beneficial ownership except to extent of pecuniary interest
RSUs outstanding (director grant)76,142Eligible to vest July 16, 2025

Ownership alignment policies:

  • Stock ownership guidelines: Outside Directors must hold vested equity equal to 5x annual cash retainer; retention of 67% of net shares until guideline met; incumbents have achieved or are expected to meet within timeframe .
  • Anti-hedging and anti-pledging: Prohibited under Insider Trading Policy .

Governance Assessment

  • Strengths:

    • Significant “skin-in-the-game” via 3.6% beneficial ownership, aligning interests with shareholders .
    • Governance policies: stock ownership guidelines, anti-hedging/pledging, clawbacks, annual Board/committee evaluations .
    • Attendance above 75% threshold; structured committee oversight (risk, nominations, compensation) .
    • Prior say-on-pay support >91% (FY2023), suggesting shareholder confidence in compensation oversight .
  • Potential conflicts and monitoring points:

    • Controlled company exemptions reduce independence requirements for Compensation and Nominating committees; Emily serves on Nominating & Corporate Governance (not required to be fully independent), increasing the need for robust nomination processes .
    • Beneficial ownership through Anthos (with spouse’s management roles) may create perceived conflicts in matters affecting large shareholders; disclosure and recusal practices should be monitored .
    • Interlocks at lululemon with other Olaplex directors increase network density; monitor for conflicts and ensure proper independence and committee practices .
  • Related-party transactions:

    • No Emily-specific related-party transactions disclosed. Company disclosed a Pacvue agreement where Advent-affiliated funds own >10%; $0.3M in payments during 2024; Audit Committee oversees RPT policy .
  • Director compensation appropriateness:

    • Mix of cash ($110k) and time-based RSUs ($150k) appears standard for sector and aligned with ownership requirements; no options or performance-based director pay disclosed for Emily .
  • RED FLAGS to watch:

    • Controlled company status and committee composition exemptions .
    • Large shareholder-linked director on Nominating Committee (perceived influence) .
    • Dense external interlocks (lululemon) among Olaplex directors .

Overall, Emily White brings deep consumer-tech monetization and brand strategy expertise with substantial equity alignment; governance risks relate to controlled-company structures and large-holder linkages requiring continued rigor in independence practices, recusal, and transparent nomination processes .